GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Equity

G.Barekat Pharm (XTEH:BRKT1) Total Equity : IRR10,564,702 Mil (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Total Equity?

G.Barekat Pharm's total equity for the quarter that ended in Mar. 2017 was IRR10,564,702 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

G.Barekat Pharm Total Equity Historical Data

The historical data trend for G.Barekat Pharm's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Total Equity Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Total Equity
- 10,564,702.00

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Total Equity - 10,564,702.00

G.Barekat Pharm Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

G.Barekat Pharm's Total Equity for the fiscal year that ended in Mar. 2017 is calculated as

Total Equity=Total Assets(Q: Mar. 2017 )-Total Liabilities(Q: Mar. 2017 )
=34818314-24253612
=10,564,702

G.Barekat Pharm's Total Equity for the quarter that ended in Mar. 2017 is calculated as

Total Equity=Total Assets(Q: Mar. 2017 )-Total Liabilities(Q: Mar. 2017 )
=34818314-24253612
=10,564,702

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

G.Barekat Pharm Total Equity Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Equity
Comparable Companies
PRGBQ BOM:532041 PZRXQ NSPX HSTC BOM:540108 XCNQ:ZRO XSAT:EURI B BOM:524604 BOM:532905 VODG BOM:506365 SOAN TSXV:WAVE PTEO BPSR CBBT LSE:PEBI ADYNF NTRR
Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
Website
http://www.bpharmed.com
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines